177 related articles for article (PubMed ID: 35608380)
21. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
[TBL] [Abstract][Full Text] [Related]
22. Strategies used in managing conversations about prostate-specific antigen (PSA) testing among family physicians (FPs): a qualitative study.
Driedger SM; Kirby S; Maier R; Süss R; Thorlacius L; Saranchuk JW; Bohm E; Singer A
BMJ Open; 2023 Apr; 13(4):e073415. PubMed ID: 37117002
[TBL] [Abstract][Full Text] [Related]
23. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.
Hayes JH; Barry MJ
JAMA; 2014 Mar; 311(11):1143-9. PubMed ID: 24643604
[TBL] [Abstract][Full Text] [Related]
24. Does shared decision making increase prostate screening uptake in countries with a low prevalence of prostate cancer?
Amin HS; Arafa MA; Farhat KH; Rabah DM; Altaweel AA; Alhammad AH
Afr Health Sci; 2020 Dec; 20(4):1870-1874. PubMed ID: 34394251
[TBL] [Abstract][Full Text] [Related]
25. Does a prior cancer diagnosis impact PSA testing? Results from the National Health Interview Survey.
Lazarovich A; Chandrasekar T; Basnet A; Bratslavsky G; Goldberg H
Can J Urol; 2023 Jun; 30(3):11551-11557. PubMed ID: 37344467
[TBL] [Abstract][Full Text] [Related]
26. The influence of physician recommendation on prostate-specific antigen screening.
Pucheril D; Dalela D; Sammon J; Sood A; Sun M; Trinh QD; Menon M; Abdollah F
Urol Oncol; 2015 Oct; 33(10):424.e1-7. PubMed ID: 26206103
[TBL] [Abstract][Full Text] [Related]
27. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
Carter HB
BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
[TBL] [Abstract][Full Text] [Related]
28. Delivering the unexpected-Information needs for PSA screening from Men's perspective: A qualitative study.
Kuss K; Adarkwah CC; Becker M; Donner-Banzhoff N; Schloessler K
Health Expect; 2021 Aug; 24(4):1403-1412. PubMed ID: 34097797
[TBL] [Abstract][Full Text] [Related]
29. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
[TBL] [Abstract][Full Text] [Related]
30. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
31. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
[TBL] [Abstract][Full Text] [Related]
32. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial.
Evans R; Joseph-Williams N; Edwards A; Newcombe RG; Wright P; Kinnersley P; Griffiths J; Jones M; Williams J; Grol R; Elwyn G
J Med Internet Res; 2010 Aug; 12(3):e27. PubMed ID: 20693148
[TBL] [Abstract][Full Text] [Related]
33. Medical Maximizing-Minimizing Preferences Predict Responses to Information about Prostate-Specific Antigen Screening.
Scherer LD; Kullgren JT; Caverly T; Scherer AM; Shaffer VA; Fagerlin A; Zikmund-Fisher BJ
Med Decis Making; 2018 Aug; 38(6):708-718. PubMed ID: 29916784
[TBL] [Abstract][Full Text] [Related]
34. Benefits and harms of prostate specific antigen testing according to Australian guidelines.
Caruana M; Gulati R; Etzioni R; Barratt A; Armstrong BK; Chiam K; Nair-Shalliker V; Luo Q; Bang A; Grogan P; Smith DP; O'Connell DL; Canfell K
Int J Cancer; 2024 Feb; 154(4):648-658. PubMed ID: 37819139
[TBL] [Abstract][Full Text] [Related]
35. Five-year downstream outcomes following prostate-specific antigen screening in older men.
Walter LC; Fung KZ; Kirby KA; Shi Y; Espaldon R; O'Brien S; Freedland SJ; Powell AA; Hoffman RM
JAMA Intern Med; 2013 May; 173(10):866-73. PubMed ID: 23588999
[TBL] [Abstract][Full Text] [Related]
36. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
O'Dell KJ; Volk RJ; Cass AR; Spann SJ
J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
[TBL] [Abstract][Full Text] [Related]
37. Pathology consultation on prostate-specific antigen testing.
Noguez JH; Fantz CR
Am J Clin Pathol; 2014 Jul; 142(1):7-15. PubMed ID: 24926079
[TBL] [Abstract][Full Text] [Related]
38. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
[TBL] [Abstract][Full Text] [Related]
39. Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure.
Carey M; Bryant J; Yoong SL; Russell G; Barker D; Sanson-Fisher R
BMC Fam Pract; 2013 Dec; 14():186. PubMed ID: 24321004
[TBL] [Abstract][Full Text] [Related]
40. A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening--a qualitative analysis.
Rychetnik L; Doust J; Thomas R; Gardiner R; Mackenzie G; Glasziou P
BMJ Open; 2014 Apr; 4(4):e004682. PubMed ID: 24785399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]